AU2008234080B2 - Production of a viable, storable worm egg suspension - Google Patents
Production of a viable, storable worm egg suspension Download PDFInfo
- Publication number
- AU2008234080B2 AU2008234080B2 AU2008234080A AU2008234080A AU2008234080B2 AU 2008234080 B2 AU2008234080 B2 AU 2008234080B2 AU 2008234080 A AU2008234080 A AU 2008234080A AU 2008234080 A AU2008234080 A AU 2008234080A AU 2008234080 B2 AU2008234080 B2 AU 2008234080B2
- Authority
- AU
- Australia
- Prior art keywords
- suspension
- eggs
- pharmaceutical preparation
- acid
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000725 suspension Substances 0.000 title claims abstract description 61
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 235000013601 eggs Nutrition 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000003755 preservative agent Substances 0.000 claims abstract description 39
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000002335 preservative effect Effects 0.000 claims abstract description 17
- 241000700605 Viruses Species 0.000 claims abstract description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- 241000233866 Fungi Species 0.000 claims abstract description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 42
- 244000005700 microbiome Species 0.000 claims description 35
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 28
- 244000000013 helminth Species 0.000 claims description 23
- 241000960389 Trichuris suis Species 0.000 claims description 19
- 238000010306 acid treatment Methods 0.000 claims description 16
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 16
- 235000010199 sorbic acid Nutrition 0.000 claims description 16
- 239000004334 sorbic acid Substances 0.000 claims description 16
- 229940075582 sorbic acid Drugs 0.000 claims description 16
- 239000005711 Benzoic acid Substances 0.000 claims description 14
- 235000010233 benzoic acid Nutrition 0.000 claims description 14
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 13
- 108010034145 Helminth Proteins Proteins 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 230000003071 parasitic effect Effects 0.000 claims description 12
- 210000000936 intestine Anatomy 0.000 claims description 11
- 230000001332 colony forming effect Effects 0.000 claims description 10
- 241000282412 Homo Species 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 8
- 208000027866 inflammatory disease Diseases 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 230000000638 stimulation Effects 0.000 claims description 7
- 230000037406 food intake Effects 0.000 claims description 6
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 claims description 5
- 208000011231 Crohn disease Diseases 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 3
- 210000003289 regulatory T cell Anatomy 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 abstract description 12
- 230000035899 viability Effects 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 5
- 241000556956 Tritrichomonas suis Species 0.000 abstract 1
- 230000035784 germination Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000714201 Feline calicivirus Species 0.000 description 3
- 241000714177 Murine leukemia virus Species 0.000 description 3
- 241000702619 Porcine parvovirus Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- FXUDFNITAMQPKO-UHFFFAOYSA-M S(O)(O)(=O)=O.C(C=CC=CC)(=O)[O-].[K+] Chemical compound S(O)(O)(=O)=O.C(C=CC=CC)(=O)[O-].[K+] FXUDFNITAMQPKO-UHFFFAOYSA-M 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000244188 Ascaris suum Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 208000006968 Helminthiasis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001489151 Trichuris Species 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- -1 p-hydroxybenzoic acid ester Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/124—Disinfecting agents, e.g. antimicrobials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07006838A EP1977643A1 (de) | 2007-04-02 | 2007-04-02 | Herstellung einer viablen, lagerfähigen Wurmeiersuspension |
| EP07006838.2 | 2007-04-02 | ||
| PCT/EP2008/002542 WO2008119534A1 (de) | 2007-04-02 | 2008-03-31 | Herstellung einer viablen, lagerfähigen wurmeiersuspension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008234080A1 AU2008234080A1 (en) | 2008-10-09 |
| AU2008234080B2 true AU2008234080B2 (en) | 2013-08-29 |
Family
ID=38330156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008234080A Ceased AU2008234080B2 (en) | 2007-04-02 | 2008-03-31 | Production of a viable, storable worm egg suspension |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9017700B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1977643A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5483731B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101646340B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE520304T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008234080B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2682525C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1111898T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2129216T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2368536T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20110715T1 (cg-RX-API-DMAC7.html) |
| ME (1) | ME01257B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2129216T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2129216E (cg-RX-API-DMAC7.html) |
| RS (1) | RS51938B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2483740C2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2129216T1 (cg-RX-API-DMAC7.html) |
| UA (1) | UA96480C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008119534A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201402909D0 (en) * | 2014-02-19 | 2014-04-02 | Univ Southampton | Treating infection |
| US9603875B1 (en) * | 2016-01-07 | 2017-03-28 | NeuOva, LLC | Method of making a consumable product with purified embryonated Trichuris suis ova |
| FR3085687B1 (fr) * | 2018-09-07 | 2021-05-14 | Nolivade | Composition et procede de conservation |
| CN109370908A (zh) * | 2018-11-16 | 2019-02-22 | 中农威特生物科技股份有限公司 | 一种鸡球虫卵囊的培养和保存液及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764838B2 (en) * | 1997-12-31 | 2004-07-20 | University Of Iowa Research Foundation | Use of parasitic biological agents for prevention and control of autoimmune diseases |
| EP1530972A2 (en) * | 2003-11-17 | 2005-05-18 | University of Iowa Research Foundation Inc. | Use of an agent produced from a parasite for prevention and control of diseases |
| WO2007076868A2 (en) * | 2005-12-30 | 2007-07-12 | Parasite Technologies A/S | Composition comprising parasite eggs and methods for isolation and storage of parasite eggs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2059417C1 (ru) * | 1992-10-01 | 1996-05-10 | Данилевич Василий Николаевич | Способ стерилизации питательных сред |
| DE10163115A1 (de) * | 2001-12-24 | 2003-07-03 | Alpha Biocare Gmbh | Reinigung und Desinfektion von Eiern von Nematoden und Plathelminthen |
-
2007
- 2007-04-02 EP EP07006838A patent/EP1977643A1/de not_active Withdrawn
-
2008
- 2008-03-31 ES ES08734901T patent/ES2368536T3/es active Active
- 2008-03-31 JP JP2010501415A patent/JP5483731B2/ja not_active Expired - Fee Related
- 2008-03-31 CA CA2682525A patent/CA2682525C/en not_active Expired - Fee Related
- 2008-03-31 EP EP08734901A patent/EP2129216B1/de active Active
- 2008-03-31 PL PL08734901T patent/PL2129216T3/pl unknown
- 2008-03-31 HR HR20110715T patent/HRP20110715T1/hr unknown
- 2008-03-31 PT PT08734901T patent/PT2129216E/pt unknown
- 2008-03-31 UA UAA200910740A patent/UA96480C2/ru unknown
- 2008-03-31 RU RU2009140308/15A patent/RU2483740C2/ru not_active IP Right Cessation
- 2008-03-31 AU AU2008234080A patent/AU2008234080B2/en not_active Ceased
- 2008-03-31 WO PCT/EP2008/002542 patent/WO2008119534A1/de not_active Ceased
- 2008-03-31 DK DK08734901.5T patent/DK2129216T3/da active
- 2008-03-31 RS RS20110416A patent/RS51938B/sr unknown
- 2008-03-31 ME MEP-2011-165A patent/ME01257B/me unknown
- 2008-03-31 AT AT08734901T patent/ATE520304T1/de active
- 2008-03-31 US US12/594,074 patent/US9017700B2/en not_active Expired - Fee Related
- 2008-03-31 CN CN2008800104022A patent/CN101646340B/zh not_active Expired - Fee Related
- 2008-03-31 SI SI200830386T patent/SI2129216T1/sl unknown
-
2011
- 2011-09-30 CY CY20111100945T patent/CY1111898T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764838B2 (en) * | 1997-12-31 | 2004-07-20 | University Of Iowa Research Foundation | Use of parasitic biological agents for prevention and control of autoimmune diseases |
| EP1530972A2 (en) * | 2003-11-17 | 2005-05-18 | University of Iowa Research Foundation Inc. | Use of an agent produced from a parasite for prevention and control of diseases |
| WO2007076868A2 (en) * | 2005-12-30 | 2007-07-12 | Parasite Technologies A/S | Composition comprising parasite eggs and methods for isolation and storage of parasite eggs |
Non-Patent Citations (1)
| Title |
|---|
| BOES, J., ERIKSEN, L., & NANSEN, P. "Embryonation and infectivity of Ascaris suum eggs ...", Veterinary Parisitology, 1998, 75, 181-190. * |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE520304T1 (de) | 2011-09-15 |
| EP2129216A1 (de) | 2009-12-09 |
| ME01257B (me) | 2013-06-20 |
| RS51938B (sr) | 2012-02-29 |
| ES2368536T3 (es) | 2011-11-18 |
| EP1977643A1 (de) | 2008-10-08 |
| DK2129216T3 (da) | 2011-10-24 |
| HRP20110715T1 (hr) | 2011-11-30 |
| PT2129216E (pt) | 2011-09-27 |
| AU2008234080A1 (en) | 2008-10-09 |
| JP2010523506A (ja) | 2010-07-15 |
| CN101646340A (zh) | 2010-02-10 |
| UA96480C2 (ru) | 2011-11-10 |
| US20110008390A1 (en) | 2011-01-13 |
| CY1111898T1 (el) | 2015-11-04 |
| CN101646340B (zh) | 2013-01-02 |
| SI2129216T1 (sl) | 2011-11-30 |
| US9017700B2 (en) | 2015-04-28 |
| PL2129216T3 (pl) | 2011-11-30 |
| CA2682525A1 (en) | 2008-10-09 |
| HK1133551A1 (en) | 2010-04-01 |
| RU2009140308A (ru) | 2011-05-10 |
| EP2129216B1 (de) | 2011-08-17 |
| RU2483740C2 (ru) | 2013-06-10 |
| CA2682525C (en) | 2015-11-17 |
| WO2008119534A1 (de) | 2008-10-09 |
| JP5483731B2 (ja) | 2014-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI114852B (fi) | Antimikrobisena aineena käytettävä hapotettu nitraatti | |
| AU2009204952B2 (en) | Bacterial ghost (BG) production process using betapropiolactone (BLP) for final inactivation | |
| EP2004800B1 (en) | Process of production of bacteriophage compositions and methods in phage therapy field | |
| US5830511A (en) | Therapeutic, production and immunostimulatory uses of biocidal compositions | |
| JP2006507378A (ja) | 安定化酸化還元特性を有する組成物および酸化還元特性の安定化法 | |
| EP2520605A1 (en) | Method for producing biocidal polyguanidine, and biocidal polyguanidine | |
| AU2008234080B2 (en) | Production of a viable, storable worm egg suspension | |
| JP2011525499A (ja) | 酢酸及び緩衝剤 | |
| Dimitrijevic et al. | Inhibitory effect of select nitrocompounds on growth and survivability of Listeria monocytogenes in vitro | |
| Kosmidis et al. | Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection | |
| CN111328811B (zh) | 一种低浓度酒精杀菌消毒液及其应用 | |
| Sennouni et al. | Antifungal activity of thymol on planktonic and biofilm cells | |
| KR102760371B1 (ko) | 식물 배지 항미생물용 조성물 | |
| RU2384335C1 (ru) | Препарат для лечения колибактериоза у молодняка сельскохозяйственных животных | |
| JP2008074797A (ja) | 魚類滑走細菌症ワクチン | |
| HK1133551B (en) | Production of a viable, storable worm egg suspension | |
| EP0981370A1 (en) | A method of preservation of vaccines with polybiguanide | |
| EP0484579A1 (en) | Stabilization of specimens for microbial analysis | |
| RU2545986C1 (ru) | Препарат траметин для лечения желудочно-кишечных болезней телят и способ его применения | |
| CN114075560A (zh) | 一种β-内酰胺酶的稳定组合物 | |
| CN118252873A (zh) | 一种带鸡消毒用聚维酮碘溶液及其制备方法 | |
| Boury et al. | Use of bacteriophage Felix01, HL18 and HL03 to reduce Salmonella enterica Typhimurium burden in mice | |
| JP2021004195A (ja) | 魚病の予防及び治療剤 | |
| BG62354B1 (bg) | Използване на българско розово масло като улцеропротективносредство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |